The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus. - Wikidata - awgldk - TriplyDB

The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus.

The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus.

http://www.wikidata.org/entity/Q34318146

about

Prevention and Treatment of Recurrent Hepatitis B after Liver Transplantation Hepatitis B virus therapy: What's the future holding for us?Hepatitis B and Delta Virus: Advances on Studies about Interactions between the Two Viruses and the Infected Hepatocyte Anti-HBV Drugs: Progress, Unmet Needs, and New Hope Management of chronic hepatitis B infection: current treatment guidelines, challenges, and new developments Solute Carrier NTCP Regulates Innate Antiviral Immune Responses Targeting Hepatitis C Virus Infection of Hepatocytes Inhibitor-Based Therapeutics for Treatment of Viral Hepatitis Current and future antiviral drug therapies of hepatitis B chronic infection Bats carry pathogenic hepadnaviruses antigenically related to hepatitis B virus and capable of infecting human hepatocytes Hepatitis B virus molecular biology and pathogenesis Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.Current hepatitis B treatment guidelines and future research directions.The Role of cccDNA in HBV Maintenance.Hepatitis B Virus Immunopathology, Model Systems, and Current Therapies Emerging antivirals for the treatment of hepatitis B.Progress in the identification of dengue virus entry/fusion inhibitors Strategies to eliminate HBV infection.Hepatitis B virus: new therapeutic perspectives.Animal models and the molecular biology of hepadnavirus infection Search for a cure for chronic hepatitis B infection: How close are we?Efficient Inhibition of Hepatitis B Virus Infection by a preS1-binding Peptide.Delta hepatitis within the Veterans Affairs medical system in the United States: Prevalence, risk factors, and outcomes.N-Glycosylation of the Na+-Taurocholate Cotransporting Polypeptide (NTCP) Determines Its Trafficking and Stability and Is Required for Hepatitis B Virus Infection.One step closer to an experimental infection system for Hepatitis B Virus? --- the identification of sodium taurocholate cotransporting peptide as a viral receptor Lentiviral hepatitis B pseudotype entry requires sodium taurocholate co-transporting polypeptide and additional hepatocyte-specific factors.Medical virology of hepatitis B: how it began and where we are now Hepatitis D Virus: A Call to Screening.Minicircle HBV cccDNA with a Gaussia luciferase reporter for investigating HBV cccDNA biology and developing cccDNA-targeting drugs.Secreted Interferon-Inducible Factors Restrict Hepatitis B and C Virus Entry In Vitro.Chimeric rodents with humanized liver: bridging the preclinical/clinical trial gap in ADME/toxicity studies.Recent insights into hepatitis B virus-host interactions.Chronic hepatitis B virus in young adults: the need for new approaches to management.Treatment options beyond IFNα and NUCs for chronic HBV infection: expectations for tomorrow.Towards an HBV cure: state-of-the-art and unresolved questions--report of the ANRS workshop on HBV cure.Recent advance of the hepatitis B virus inhibitors: a medicinal chemistry overview.Advances in therapeutics for chronic hepatitis B.New paradigms in hepatitis B management: only diamonds are forever.Lymphocytes transiently expressing virus-specific T cell receptors reduce hepatitis B virus infection.Viral life cycle of hepatitis B virus: Host factors and druggable targets.Hepatitis B: treatment choice and monitoring for response and resistance.

P2860

Q26751777-9A68735D-ACA6-46C9-BFCE-44603BCF079D Q26774198-BF4C549B-5E4B-45BE-BC23-6DC6C4DBB5D4 Q26775635-54402735-BF70-42E8-96C5-701604ACC46D Q26782742-F2381739-C357-4AA4-B424-2E39B09AE400 Q27008984-FC57CE04-5FF1-41C4-A4F1-30674CEFD632 Q27928046-B7B6715C-1AE7-444E-873E-3DA1110B9BDE Q28073697-2916562C-19AC-487B-901A-7132C3ACA7A3 Q28084820-E0428693-D364-4AFA-81E8-AEA18968BEA8 Q28676360-FBB7C6AD-37CD-43F4-BC74-1A28105F8416 Q28818406-2F20B634-E0C2-492E-A2A9-F7B06E9E762C Q30391932-5D3A116D-85F8-4DDA-B973-3B1C7E7D2696 Q30487002-B6A44E20-A842-4F70-8D30-9BB44E1CC660 Q32182914-D3A3408F-F419-41CA-BDB5-464BF35FBEF0 Q33559657-71F73E8A-C4A9-49BA-933A-437C80AF7EAF Q33801328-B462821F-C002-49BF-BF08-7D83FDDFFB31 Q34054616-333FCFDD-8E85-46BC-B211-D074EBC52885 Q34308129-F0EE86FA-F090-4FC0-83B5-288DCACEAEEF Q34507250-5C5B0560-D20C-4955-9BAE-2247E942DE90 Q35245221-9264631F-25EB-4E78-BE1E-868EC30B69AD Q35626790-E773986F-4241-451B-84F0-86D9166F3190 Q36069081-FF280053-DC31-4281-970B-4F878A2C3EA4 Q36072747-11489A50-23E2-454D-92A4-1224E638B9E1 Q36260961-AEBB3C8D-AB4E-42F6-A055-C69ED66C6904 Q36581581-0437C3B2-3A61-4AB6-BB82-8844E27B875A Q36635229-4C798208-D129-4C66-8138-5CA3B7E374AF Q37059714-66FDF8A3-9D7D-4BB9-88A5-45A70635A3AE Q37182821-9C0FC52F-CBD0-4101-9143-304ECDBDA59F Q37397410-6CE67C7D-4828-42C4-A3BE-537332608E81 Q37711751-02AFEA21-6FBE-467D-8894-AA09E31BB4CE Q38169790-F69ABEB1-AFFF-42E4-A3BD-D13F965D7AEF Q38194061-43F12C0E-EFA2-49C5-ADF9-CF0363AC2341 Q38232829-45DAA660-F734-4203-A6B9-0F3867D3B1A3 Q38255840-777D4B03-8C85-4B31-A648-7AE75D988DDF Q38351585-40A7F5F9-6491-45AF-ABB4-25BE1F750661 Q38447283-68F111D2-1BD4-4CFE-B07C-141BC774CF05 Q38585657-F668434F-4824-49A0-94EE-D56EB10BEB84 Q38588187-85C2D678-4670-4F5F-82ED-D65DF9FDA6E8 Q38665181-2BF4D3A3-D12A-4374-94F1-880E5788E8D5 Q38699649-DDA93348-A8BC-4881-BAA7-4A386D94F6F4 Q38707903-4E7AC265-F53F-4B24-9361-D0DB814B36CF

P2860

The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus.

http://www.wikidata.org/entity/Q34318146

description

2012 nî lūn-bûn

@nan

2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

The entry inhibitor Myrcludex- ...... fected with hepatitis B virus.

@ast

The entry inhibitor Myrcludex- ...... fected with hepatitis B virus.

@en

The entry inhibitor Myrcludex- ...... fected with hepatitis B virus.

@nl

type

label

The entry inhibitor Myrcludex- ...... fected with hepatitis B virus.

@ast

The entry inhibitor Myrcludex- ...... fected with hepatitis B virus.

@en

The entry inhibitor Myrcludex- ...... fected with hepatitis B virus.

@nl

prefLabel

The entry inhibitor Myrcludex- ...... fected with hepatitis B virus.

@ast

The entry inhibitor Myrcludex- ...... fected with hepatitis B virus.

@en

The entry inhibitor Myrcludex- ...... fected with hepatitis B virus.

@nl

P1433

Q34318146-63D6F4F9-6BA9-4975-BDBD-A28321040F79

P1476

Q34318146-7DB09E75-D5D3-470A-BCD0-DB377182CF0F

P2093

Q34318146-181F0AFD-EFE1-4159-961A-C329827C6FB0

Q34318146-3F4EF09A-6D5A-4311-941B-BB7206BDB1CC

Q34318146-5E5D8494-2F6D-4883-9043-B16068D93020

Q34318146-76D809C2-EF53-4A8E-8627-BB1858B585A1

Q34318146-817BF8D1-94E4-4478-B1EE-80209D6D7428

Q34318146-887DAC8C-12DA-4869-8ACB-5E8D6433BDFE

Q34318146-B1A08138-57EE-4F3D-94DC-98EA0688BFBD

Q34318146-CEB73399-5F11-4FDD-973F-5B8E9AF2B3B9

Q34318146-E82DC347-4893-424E-B08A-7B40EDD79D7A

P304

Q34318146-AFECBB4E-DE20-411A-AFE6-EE98BBDD0A8E

P31

Q34318146-6512CFA2-BCD6-4EAF-8E83-1D42DC747C6E

P356

Q34318146-C073B755-565F-45EB-8E17-1B09DFE57C04

P433

Q34318146-4E8E3627-039A-4D07-B591-6BBCC0F119C6

P478

Q34318146-CA6F9989-20B3-4832-8678-E5073959CCD7

P50

Q34318146-709FE45D-F93E-4081-9A23-37D9D0DE5060

Q34318146-929691B2-EADB-4D22-AD40-F75D393409DE

P577

Q34318146-8364B6AA-3266-4F71-A327-0F412788F634

P5875

Q34318146-986FE700-06AA-43A2-87F9-674C37850FD7

P698

Q34318146-5874891D-F86B-477D-A80D-D0935DB6EBCF

P356

J.JHEP.2012.12.008

P1433

Journal of Hepatology

P1476

The entry inhibitor Myrcludex- ...... nfected with hepatitis B virus

@en

P2093

Alexander Alexandrov

http://www.w3.org/2001/XMLSchema#string

Ansgar W Lohse

http://www.w3.org/2001/XMLSchema#string

Jörg M Pollok

http://www.w3.org/2001/XMLSchema#string

Jörg Petersen

http://www.w3.org/2001/XMLSchema#string

Lena Allweiss

http://www.w3.org/2001/XMLSchema#string

Marc Lütgehetmann

http://www.w3.org/2001/XMLSchema#string

Maura Dandri

http://www.w3.org/2001/XMLSchema#string

Mounira Ben MBarek

http://www.w3.org/2001/XMLSchema#string

Stephan Urban

http://www.w3.org/2001/XMLSchema#string

P304

861-867

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JHEP.2012.12.008

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P50

Michael Warlich

P577

2012-12-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233940264

http://www.w3.org/2001/XMLSchema#string

P698

23246506

http://www.w3.org/2001/XMLSchema#string